构造工程,BSA结合和计算分析含有1,2,4-三醇的基于异尼酸盐的酶抑制剂
Naeem A Virk1, Aziz-Ur-Rehman1, Javed Iqbal2
1Department of Chemistry, Government College University, Lahore, Pakistan.
PloS one
|January 7, 2026
概括
这项研究使用微波辅助方法合成了基于piperidine的新型1,2,4-triazole类似物,具有高产量. 几种化合物对乙胆酶 (AChE),丁胆酶 (BChE) 和15-氧基酶 (15-LOX) 酶表现出显著的抑制活性.
科学领域:
- 药用化学 医学化学
- 有机合成 有机合成
- 酶抑制可以抑制酶.
背景情况:
- 激活C-C,C-S和C-N双键的挑战在合成化学中已经存在很长时间了.
- 开发针对合环系统内的C-N,N-N和C-S键的新型化合物对于治疗进步至关重要.
研究的目的:
- 为了合成基于piperidine的新型1,2,4-triazole类似物.
- 为了评估合成的类似物对主要酶的抑制潜力,包括乙胆化酶 (AChE),丁胆化酶 (BChE),15-lipoxygenase (15-LOX) 和α-Glucosidase.
- 通过分子对接和牛血清白蛋白 (BSA) 结合研究来确认体外发现.
主要方法:
- 使用常规和微波辅助技术,无金属合成基于piperidine的1,2,4-triazole类似物 (7a-j).
- 合成化合物的结构特征使用质子和碳NMR和IR光谱学.
- 在体外对类似物进行AChE,BChE,15-LOX和α-Glucosidase的查,然后进行分子对接和BSA结合试验.
主要成果:
- 与传统方法 (59-72%) 相比,微波辅助合成产生了有针对性的分子 (7a-j),产量明显更高 (87-95%).
- 化合物7h,7c和7i对ACHE表现出强烈的抑制,IC50值处于微分子范围.
- 类似物7i和7e对15-LOX表现出显著的活性,优于标准Quercetin,而许多类似物对α-Glucosidase表现出很好的抑制,超过了acarbose.
结论:
- 合成的基于piperidine的1,2,4-triazole类似物代表了开发新型治疗剂的有希望的化合物.
- 化合物7h,7c和7i被确定为潜在的胆酶抑制剂,7i化合物被确定为潜在的15-LOX抑制剂.
- 进一步的体内研究是有必要的,以探索这些衍生物的治疗潜力,作为治疗重要酶的抑制剂.
更多相关视频
08:56Synthesis of 1,2-Azaborines and the Preparation of Their Protein Complexes with T4 Lysozyme Mutants
Published on: March 25, 2017
8.0K
10:33Development of Inhibitors of Protein-protein Interactions through REPLACE: Application to the Design and Development Non-ATP Competitive CDK Inhibitors
Published on: October 26, 2015
11.8K
相关概念视频
Enzyme Inhibition
91.5K
Inhibitors are molecules that reduce enzyme activity by binding to the enzyme. In a normally functioning cell, enzymes are regulated by a variety of inhibitors. Drugs and other toxins can also inhibit enzymes. Some inhibitors bind to the enzyme’s active site, while others inhibit enzymatic activity by binding to other sites on the protein structure.
91.5K
Ligand Binding and Linkage
5.5K
Allosteric proteins have more than one ligand binding site; the binding of a ligand to any of these sites influences the binding of ligands to the other sites. When a protein is allosteric, its binding sites are called coupled or linked. In the case of enzymes, the site that binds to the substrate is known as the active site and the other site is known as the regulatory site. When a ligand binds to the regulatory site, this leads to conformational changes in the protein that can influence...
5.5K
The Equilibrium Binding Constant and Binding Strength
14.8K
The equilibrium binding constant (Kb) quantifies the strength of a protein-ligand interaction. Kb can be calculated as follows when the reaction is at equilibrium:
14.8K
Allosteric Proteins-ATCase
6.5K
Binding sites linkages can regulate a protein's function. For example, enzyme activity is often regulated through a feedback mechanism where the end product of the biochemical process serves as an inhibitor.
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis...
6.5K
Enzymes
93.8K
Inside living organisms, enzymes act as catalysts for many biochemical reactions involved in cellular metabolism. The role of enzymes is to reduce the activation energies of biochemical reactions by forming complexes with its substrates. The lowering of activation energies favor an increase in the rates of biochemical reactions.
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
Enzyme deficiencies can often translate into life-threatening diseases. For example, a genetic abnormality resulting in the deficiency of the enzyme G6PD...
93.8K
Structure-Activity Relationships and Drug Design
1.7K
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
1.7K
